Ignite Creation Date:
2024-05-05 @ 11:28 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00056641
Status:
COMPLETED
Last Update Posted:
2023-12-01
First Post:
2003-03-19
Brief Title:
Dual Boosted - Protease Inhibitor PI Pharmacokinetics PK Trial Tipranavir Ritonavir in Highly Treatment-experienced HIV-1 Infected Patients
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-02-18
Start Date Type:
ACTUAL
Primary Completion Date:
2004-01-27
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2003-03-19
First Submit QC Date:
March 20 2003
Study First Post Date:
2003-03-21
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-30
Last Update Post Date:
2023-12-01
Last Update Post Date Type:
ACTUAL